CXCL10 and melanoma: Increased IL-12, on the other hand, contributes to boost the innate immune response while the increase of the anti-angiogenic factor CXCL10 together with a decreased VEGF level counteracts neo-angiogenesis and thereby likely contributes to the observed shrinkage of the melanoma lesions.